Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,124.15
(
0.45%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,004.02
(
-1.12%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

skitahoe

Send PM Follow Ignore
Followers 249
Posts 15542
Boards Moderated 1
Alias Born 08/14/2003

skitahoe

Re: DewDiligence post# 94746

Friday, 06/04/2010 1:05:15 PM

Friday, June 04, 2010 1:05:15 PM

Post# of 257253
J&J has cut back dramatically on research in the past. IMGN now owns a drug they originally developed for J&J's CNTO unit because of the funding cut. Results for IMGN388 should be reported soon. CNTO does have Opt In rights.

I believe this is a weakness in J&J, not a strength.

Gary
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now